For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Doctors’ dilemma
+Columns
Doctors’ dilemma
Wednesday 29 May 2019, 07:15 AM

Should we plant fast-growing exotics to offset carbon emissions or slow-growing New Zealand natives for biodiversity?
GP Jim Vause gets serious about extinction rebellion and medicine’s role in keeping too many people on the planet
Ultimately, we are battling ourselves for we are up against the ultimate meaning of life, the human propensity for DNA preservation
I have a con
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.